SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells.

被引：0
|
作者：
Jain, Nayan [1 ]
Zhao, Zeguo [1 ]
Koche, Richard [1 ]
Gozlan, Yosi [2 ]
Brocks, David [2 ]
Raveh-Sadka, Tali [2 ]
Wells, Danny [3 ]
Dobrin, Anton [1 ]
Shi, Yuzhe [1 ]
Lopez, Michael [1 ]
Gunset, Gertrude [1 ]
Sadelain, Michel [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Immunai, Tel Aviv, Israel
[3] Immunai, San Francisco, CA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5583
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Mitochondrial Reprogramming By Bcl-2 Inhibitor Venetoclax Enhances αCD19 CAR-T Cell Fitness and Anti-Tumor Efficacy
    Mandeville, Taylor K.
    Mavis, Cory
    Gu, Juan
    Bowman, Kevin
    Olejniczak, Scott
    Dey, Prasenjit
    Paragh, Gyorgy
    Cortese, Matthew J.
    Hernandez-Ilizaliturri, Francisco J.
    BLOOD, 2023, 142
  • [42] Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells
    Miao, Guojuan
    Sun, Xiuhong
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 141
  • [43] Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC
    Harrasser, Micaela
    Gohil, Satyen Harish
    Lau, Hiu
    Della Peruta, Marco
    Muczynski, Vincent
    Patel, Dominic
    Miranda, Elena
    Grigoriadis, Kristiana
    Grigoriadis, Anita
    Granger, David
    Evans, Rachel
    Nathwani, Amit Chunilal
    BREAST CANCER RESEARCH, 2022, 24 (01)
  • [44] PD-1 blocking strategy for enhancing the anti-tumor effect of CAR T cells targeted CD105
    Wang, Xi
    Lai, Zhiheng
    Pang, Yanyang
    Sun, Qinghui
    Yang, Wenli
    Wang, Wu
    HELIYON, 2023, 9 (01)
  • [45] Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC
    Micaela Harrasser
    Satyen Harish Gohil
    Hiu Lau
    Marco Della Peruta
    Vincent Muczynski
    Dominic Patel
    Elena Miranda
    Kristiana Grigoriadis
    Anita Grigoriadis
    David Granger
    Rachel Evans
    Amit Chunilal Nathwani
    Breast Cancer Research, 24
  • [46] Construction of PD1/CD28 chimeric-switch receptor enhances anti-tumor ability of c-Met CAR-T in gastric cancer
    Chen, Cong
    Gu, Yan-Mei
    Zhang, Fan
    Zhang, Zheng-Chao
    Zhang, Ya-Ting
    He, Yi-Di
    Wang, Ling
    Zhou, Ning
    Tang, Fu-Tian
    Liu, Hong-Jian
    Li, Yu-Min
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [47] PD-1 silencing improves anti-tumor activities of human mesothelin-targeted CAR T cells
    Liu, Guodi
    Zhang, Qian
    Li, Dehua
    Zhang, Linsong
    Gu, Zhangjie
    Liu, Jibin
    Liu, Guoping
    Yang, Mu
    Gu, Jinwei
    Cui, Xingbing
    Pan, Yingjiao
    Tian, Xiaoli
    HUMAN IMMUNOLOGY, 2021, 82 (02) : 130 - 138
  • [48] CD72 Nanobody-Based CAR-T Cells Have Potent Anti-Tumor Efficacy in B Cell Malignancies
    Nix, Matthew A.
    Temple, William C.
    Karlon, William
    Wang, Donghui
    Phojanakong, Paul
    Steri, Veronica
    Hann, Byron
    Wiita, Arun P.
    BLOOD, 2021, 138
  • [49] Knockdown of circZMIZ1 enhances the anti-tumor activity of CD8+ T cells to alleviate hepatocellular carcinoma
    Li, Xi
    Wu, Anlin
    Wang, Yixian
    Li, Die
    Wu, Mingming
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2024, 24 (01)
  • [50] Knockdown of circZMIZ1 enhances the anti-tumor activity of CD8+ T cells to alleviate hepatocellular carcinoma
    Xi Li
    Anlin Wu
    Yixian Wang
    Die Li
    Mingming Wu
    Functional & Integrative Genomics, 2024, 24
12345